92769 ⎘
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
(METH)ACRYLAMIDE COMPOUND, MONOMER COMPOSITION, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL
#2ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF
#3PHOTOPOLYMERIZABLE ANTIBACTERIAL MONOMER
#4TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF
#5COMPOUNDS AND METHODS TO ATTENUATE TUMOR PROGRESSION AND METASTASIS
#6Sensors for detection of negatively charged phosphate-containing membranes and membrane components
#7Resin composition
#8Myocyte enhancer factor 2 (MEF2) modulators
#9Two-dimensional nanomaterial dispersant, preparation method of two-dimensional nanomaterial by liquid phase exfoliation, and use thereof
#10IDO inhibitors
#11RUBBER COMPOSITION
#12Tire member manufacturing method and tire manufacturing method
#13Multivalent compounds for use in the treatment and prevention of brain damage
#142,2′-diaminobiaryls having two secondary amines
#15Electrochromic element and electrochromic dimming element
#16Acrylamide-based crosslinking monomers, their preparation, and uses thereof
#17Excimer forming compounds
#18Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#19Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer
#20Treatment of friedreich's ataxia using histone deacetylase inhibitors
#21Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof
#22Fulvene and fulvalene analogs and their use in treating cancers
#23Chalcone structure fluorescence dye for embryonic stem cell probe
#24Treatment of friedreich's ataxia using histone deacetylase inhibitors
#25Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#261, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
#27Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2
#28NOVEL POLYMERIZABLE MONOMER AND POLYMER OF THE POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING THE POLYMER
#29NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER
#301, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
#31TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS
#32Histone deacetylase inhibitors
#33Method for producing alkaline (meth)acrylamides
#34SYNTHESIS, TELOMERASE INHIBITION AND CYTOTOXIC STUDIES ON 2,7-DISUBSTITUTED ANTHRAQUINONE DERIVATIVES
#35PREPARATION OF FUNCTIONAL MONOMERS FOR GRAFTING TO LOW MOLECULAR WEIGHT POLYALKENES AND THEIR USE IN THE PREPARATION OF DISPERSANTS AND LUBRICATING OIL COMPOSITIONS CONTAINING DISPERSANT POLYALKENES
#36Preparation of functional monomers for grafting to low molecular weight polyalkenes and their use in the preparation of dispersants and lubricating oil compositions containing dispersant polyalkenes
#37FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
#38Calcium receptor modulating agents
#39N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
#40OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
#41Histone deacetylase inhibitors as therapeutics for neurological diseases
#42Melanin concentrating hormone antagonist
#43Substituted p-diaminobenzene derivatives
#44Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
#45Process for the preparation of 4-oxo-4-((4-(phenylamino)phenyl)amino)-2-butenoic acid
#46Inhibitors of histone deacetylase
#47Inhibitors of histone deacetylase
#48Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
#49Preparation of functional monomers for grafting to low molecular weight polyalkenes and their use in the preparation of dispersants and lubricating oil compositions containing dispersant polyalkenes
#50Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
#51Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#52Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical aggents comprising the same as active ingredient